New Look of EBV LMP1 Signaling Landscape

The Epstein–Barr Virus (EBV) principal oncoprotein Latent Membrane Protein 1 (LMP1) is a member of the Tumor Necrosis Factor Receptor (TNFR) superfamily with constitutive activity. LMP1 shares many features with Pathogen Recognition Receptors (PRRs), including the use of TRAFs, adaptors, and kinase...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ling Wang, Shunbin Ning
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
EBV
p62
Acceso en línea:https://doaj.org/article/46b4200b411a4c34862978d91af4055f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:46b4200b411a4c34862978d91af4055f
record_format dspace
spelling oai:doaj.org-article:46b4200b411a4c34862978d91af4055f2021-11-11T15:33:24ZNew Look of EBV LMP1 Signaling Landscape10.3390/cancers132154512072-6694https://doaj.org/article/46b4200b411a4c34862978d91af4055f2021-10-01T00:00:00Zhttps://www.mdpi.com/2072-6694/13/21/5451https://doaj.org/toc/2072-6694The Epstein–Barr Virus (EBV) principal oncoprotein Latent Membrane Protein 1 (LMP1) is a member of the Tumor Necrosis Factor Receptor (TNFR) superfamily with constitutive activity. LMP1 shares many features with Pathogen Recognition Receptors (PRRs), including the use of TRAFs, adaptors, and kinase cascades, for signal transduction leading to the activation of NFκB, AP1, and Akt, as well as a subset of IRFs and likely the master antioxidative transcription factor NRF2, which we have gradually added to the list. In recent years, we have discovered the Linear UBiquitin Assembly Complex (LUBAC), the adaptor protein LIMD1, and the ubiquitin sensor and signaling hub p62, as novel components of LMP1 signalosome. Functionally, LMP1 is a pleiotropic factor that reprograms, balances, and perturbs a large spectrum of cellular mechanisms, including the ubiquitin machinery, metabolism, epigenetics, DNA damage response, extracellular vehicles, immune defenses, and telomere elongation, to promote oncogenic transformation, cell proliferation and survival, anchorage-independent cell growth, angiogenesis, and metastasis and invasion, as well as the development of the tumor microenvironment. We have recently shown that LMP1 induces p62-mediated selective autophagy in EBV latency, at least by contributing to the induction of p62 expression, and Reactive Oxygen Species (ROS) production. We have also been collecting evidence supporting the hypothesis that LMP1 activates the Keap1-NRF2 pathway, which serves as the key antioxidative defense mechanism. Last but not least, our preliminary data shows that LMP1 is associated with the deregulation of cGAS-STING DNA sensing pathway in EBV latency. A comprehensive understanding of the LMP1 signaling landscape is essential for identifying potential targets for the development of novel strategies towards targeted therapeutic applications.Ling WangShunbin NingMDPI AGarticleEBVLMP1LIMD1LUBACp62Neoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENCancers, Vol 13, Iss 5451, p 5451 (2021)
institution DOAJ
collection DOAJ
language EN
topic EBV
LMP1
LIMD1
LUBAC
p62
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle EBV
LMP1
LIMD1
LUBAC
p62
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Ling Wang
Shunbin Ning
New Look of EBV LMP1 Signaling Landscape
description The Epstein–Barr Virus (EBV) principal oncoprotein Latent Membrane Protein 1 (LMP1) is a member of the Tumor Necrosis Factor Receptor (TNFR) superfamily with constitutive activity. LMP1 shares many features with Pathogen Recognition Receptors (PRRs), including the use of TRAFs, adaptors, and kinase cascades, for signal transduction leading to the activation of NFκB, AP1, and Akt, as well as a subset of IRFs and likely the master antioxidative transcription factor NRF2, which we have gradually added to the list. In recent years, we have discovered the Linear UBiquitin Assembly Complex (LUBAC), the adaptor protein LIMD1, and the ubiquitin sensor and signaling hub p62, as novel components of LMP1 signalosome. Functionally, LMP1 is a pleiotropic factor that reprograms, balances, and perturbs a large spectrum of cellular mechanisms, including the ubiquitin machinery, metabolism, epigenetics, DNA damage response, extracellular vehicles, immune defenses, and telomere elongation, to promote oncogenic transformation, cell proliferation and survival, anchorage-independent cell growth, angiogenesis, and metastasis and invasion, as well as the development of the tumor microenvironment. We have recently shown that LMP1 induces p62-mediated selective autophagy in EBV latency, at least by contributing to the induction of p62 expression, and Reactive Oxygen Species (ROS) production. We have also been collecting evidence supporting the hypothesis that LMP1 activates the Keap1-NRF2 pathway, which serves as the key antioxidative defense mechanism. Last but not least, our preliminary data shows that LMP1 is associated with the deregulation of cGAS-STING DNA sensing pathway in EBV latency. A comprehensive understanding of the LMP1 signaling landscape is essential for identifying potential targets for the development of novel strategies towards targeted therapeutic applications.
format article
author Ling Wang
Shunbin Ning
author_facet Ling Wang
Shunbin Ning
author_sort Ling Wang
title New Look of EBV LMP1 Signaling Landscape
title_short New Look of EBV LMP1 Signaling Landscape
title_full New Look of EBV LMP1 Signaling Landscape
title_fullStr New Look of EBV LMP1 Signaling Landscape
title_full_unstemmed New Look of EBV LMP1 Signaling Landscape
title_sort new look of ebv lmp1 signaling landscape
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/46b4200b411a4c34862978d91af4055f
work_keys_str_mv AT lingwang newlookofebvlmp1signalinglandscape
AT shunbinning newlookofebvlmp1signalinglandscape
_version_ 1718435236351574016